Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

<h4>Introduction</h4>Patients with significant liver fibrosis (SF) are likely to progress to advanced chronic liver disease (ACLD). Therefore, liver-directed therapy is indicated. The European Association for the Study of the Liver-2024 (EASL) recommends annual screening of patients with diabetes fo...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Chamila Mettananda, Chamila Ranawaka, Thimira Egodage, Channaka Dantanarayana, Rumal Fernando, Lakmali Ranaweera, Dulani Kottahachchi, Shirom Siriwardhana, Arunasalam Pathmeswaran, Anuradha Dassanayake, Janaka de Silva
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Public Library of Science (PLoS) 2026-01-01
سلاسل:	PLoS ONE
الوصول للمادة أونلاين:	https://doi.org/10.1371/journal.pone.0341364
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

مواد مشابهة